Am J Transplant, Volume 18, Suppl 3 Archives - Page 179 of 211 - ATC Abstracts

2018 American Transplant Congress
Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation
J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Patients (pts) with prior transplants, blood transfusions, and pregnancies awaiting heart transplantation (HTx) have potential to develop circulating anti-HLA antibodies (HLA Abs). Pts at…
2018 American Transplant Congress
Left Ventricular Assist Devices Complicated by Gastrointestinal Bleeding and Outcomes on Transplant
L. Aurora, O. Sadiq, H. Nemeh, C. Williams.
Internal Medicine, Cardiac Surgery, Cardiology, Henry Ford Hospital, Detroit.
Left Ventricular Assist Devices (LVAD) are becoming the standard of care in advanced heart failure patients. However, despite ongoing advances in this technology, there remains…
2018 American Transplant Congress
The Kidney Allocation System from the Perspective of a Small Program in a Donor Service Area
K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² S. Hanna,² J. Africa.¹
¹Glickman Institute, Cleveland Clinic, Cleveland, OH; ²Urology and Renal Transplant, Charleston Area Medical Center, Charleston, WV.
This study investigated the impact of the new kidney allocation system (KAS) on a small transplant program (SP) when compared with the 3 other centers…
2018 American Transplant Congress
Exploring the Impact of Recipient Age with Kidney Donor Risk Index and Estimated Glomerular Filtration Rate at One Year Following Kidney Transplant
S. Chan,^1,2,3 M. Chatfield,⁴ K. Baboolal.^2,3
¹Australian and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia; ²Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; ³Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; ⁴Statistics Unit, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
Background: Various kidney donor risk indexes (KDRI) have been developed to predict graft survival with various combinations of donor and recipient characteristics. The aim of…
2018 American Transplant Congress
Improving Participation in Non-A1/Non-A1B to B Deceased Donor Program Post Kidney Allocation System (KAS)- A Single Center Experience
H. Khamash, J. Adamski, R. Heilman, A. Mathur, A. Moss, A. Kumar, Q. Lu, K. Reddy.
Mayo Clinic Arizona, Phoenix.
Blood type B kidney transplant candidates have a longer wait time on the deceased donor list, an average of 6 years compared to 3 years…
2018 American Transplant Congress
Lack of Efficacy of Eculizumab for Prevention of Delayed Graft Function (DGF) in Deceased Donor Kidney Transplant Recipients
P. Heeger,¹ E. Akalin,² M. Baweja,¹ R. Bloom,³ S. Florman,¹ B. Haydel,¹ D. Hricik,⁴ S. Kulkarni,⁵ A. Mehrotra,¹ A. Patel,⁶ E. Poggio,⁷ L. Ratner,⁸ S. Schröppel,¹ R. Shapiro.¹
¹Mount Sinai Hosp, NY, NY; ²Montefiore Hosp, NY, NY; ³Hosp U Pa, Phila, PA; ⁴U Hosp Cleveland, Cleveland, OH; ⁵Yale U Hosp, New Haven, CT; ⁶St Barnabas Med Ctr, Livingston, NJ; ⁷Cleveland Clinic, Cleveland, OH; ⁸Columbia-Presbyterian Hosp, NY, NY.
DGF portends poor short- and long-term renal function, increases cost, and may reduce graft survival. We studied the safety/efficacy of eculizumab (ECU), a C5 convertase…
2018 American Transplant Congress
Age Stratified Efficacy and Safety Outcomes of Induction Immunosuppression in Renal Transplantation
D. McKimmy,¹ H. Kuzaro,² S. Sakya,³ K. Belfield,¹ E. Cohen.¹
¹Solid Organ Transplant, Yale New Haven Hospital, New Haven, CT; ²University of St. Joseph School of Pharmacy, West Hartford, CT; ³University of Connecticut School of Pharmacy, Storrs, CT.
Purpose: Rejection and infection remain a leading concern for decreased graft survival after renal transplant (RT). Induction immunosuppression is associated with a decreased risk of…
2018 American Transplant Congress
Is It Better Choice to Perform Kidney Transplantation for Elderly CKD Patients?
R. Imamura,¹ K. Tsutahara,² K. Yamanaka,³ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ T. Abe,¹ H. Kishikawa,³ N. Ichimaru,⁴ K. Nishimura,³ S. Yamaguchi,² N. Nonomura.¹
¹Urology, Osaka University Graduate School of Medicine, Suita, Japan; ²Urology, Osaka General Medical Center, Osaka, Japan; ³Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan; ⁴Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
[Objectives] Japan is forecasted to become an aged society with 30.3% and 39.9% in 2025 and 2060, respectively. Along with that, the number of elderly…
2018 American Transplant Congress
Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients
E. Tang, A. Bansal, S. Cao, M. Li, M. Novak, I. Mucsi.
University Health Network, Toronto, Canada.
Background: The Patient Reported Outcomes Measurement Information System (PROMIS) provides generalizable and universal measures of various domains of patient reported outcomes. The PROMIS-57 and PROMIS-29…
2018 American Transplant Congress
A Theoretical Framework to Explain Factors That Impact Completion of the Medical Evaluation Process for African American (AA) End-Stage Renal Disease (ESRD) Patient
C. Nonterah,¹ H. Gardiner,² D. Vavra.¹
¹Psychology, University of Richmond, Richmond, VA; ²Department of Social and Behavioral Sciences, Temple University, Philadelphia, PA.
Black/African Americans (B/AA) are less likely to seek kidney transplantation or complete the pre-transplant medical evaluation despite higher prevalence rates of end-stage renal disease (ESRD).…